Indication
respiratory disease
12 clinical trials
19 products
1 drug
Product
Probiotic 1Clinical trial
Efficacy of Physiological Saline and Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children Aged 2-6, in Son Tay Province, HanoiStatus: Recruiting, Estimated PCD: 2024-09-01
Product
ProbioticProduct
0.9% NaClProduct
Probiotic 2Product
VapendavirClinical trial
A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus ChallengeStatus: Recruiting, Estimated PCD: 2024-12-30
Product
PlaceboClinical trial
A Phase 1 Study to Confirm the Single- and Multiple-dose Pharmacokinetics and to Evaluate Food Effect of Vapendavir in Healthy Participants and Participants With COPDStatus: , Estimated PCD: 2023-08-01
Clinical trial
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre TransplantationStatus: Terminated, Estimated PCD: 2023-09-27
Product
SeretideClinical trial
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Drug In Management Of Persistent Pulmonary Hypertension Of NewbornsStatus: Recruiting, Estimated PCD: 2024-08-20
Product
Nebulized nitroglycerineClinical trial
Impact of Spa Treatments on the Consumption of Care in ChildrenStatus: Completed, Estimated PCD: 2022-12-31
Product
Drug consumptionProduct
PPHNClinical trial
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic RhinitisStatus: , Estimated PCD: 2025-09-07
Clinical trial
Caffeine for Late Preterm Infants: A Double Blind Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
Caffeine citrateClinical trial
Total Intravenous Anesthesia for Rigid Bronchoscopy - Remimazolam Versus Propofol: a Prospective Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2024-04-01
Product
RemimazolamProduct
PropofolClinical trial
Hypersensitivity Pneumonitis of Domestic Origin: Investigation of the Microorganisms Involved and Improvement of Serological Diagnosis.Status: Not yet recruiting, Estimated PCD: 2026-03-01
Product
Blood SampleClinical trial
Early Nintedanib Deployment in COVID-19 Interstitial Lung DiseaseStatus: Completed, Estimated PCD: 2024-02-01
Product
NintedanibDrug
VarlilumabClinical trial
Open-Label, Single Dose, Parallel Group, Phase 1 Study in Healthy Volunteers Evaluating Safety, Tolerability, Pharmacokinetics, and Immunogenicity AIO-001 Administered by InjectionsStatus: Active (not recruiting), Estimated PCD: 2024-12-20
Product
AIO-001